GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Asiatic Laboratories Ltd (DHA:ASIATICLAB) » Definitions » Current Deferred Revenue

Asiatic Laboratories (DHA:ASIATICLAB) Current Deferred Revenue : BDT0.00 Mil (As of . 20)


View and export this data going back to 2024. Start your Free Trial

What is Asiatic Laboratories Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Asiatic Laboratories's current deferred revenue for the quarter that ended in . 20 was BDT0.00 Mil.

Asiatic Laboratories Current Deferred Revenue Historical Data

The historical data trend for Asiatic Laboratories's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asiatic Laboratories Current Deferred Revenue Chart

Asiatic Laboratories Annual Data
Trend
Current Deferred Revenue

Asiatic Laboratories Semi-Annual Data
Current Deferred Revenue

Asiatic Laboratories Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Asiatic Laboratories's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Asiatic Laboratories (DHA:ASIATICLAB) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Siddeshwari Circular Road, 42-43, Treasure Island (5 th Floor) Shantinagar, Dhaka, BGD, 1217
Asiatic Laboratories Ltd is engaged in manufacturing and marketing of a wide range of the rapeutical medicines pharmaceutical products in the categories of Biological, Non-Biological & Sterile Pharmaceutical dosage. It has 80 generic molecules comprising therapeutic classes like antibiotics, antihistamines, bronchodilators, vitamins-minerals, antiulcerants, laxatives, gastroprokinetics, antihematinic, anthelmentics, CNS drugs, respiratory drugs, NSAIDs, dermatological preparations and sterile ophthalmic preparations.

Asiatic Laboratories (DHA:ASIATICLAB) Headlines

No Headlines